chance, to drive these companies stock prices considerably through the rest of the year and beyond. Alexion Pharmaceuticals (NASDAQ: ALXN ) Alexion is a biopharmaceutical company that discovers, develops and commercializes medicines for
Alexion Pharmaceuticals (NASDAQ: ALXN ) submits a New Drug Application to the Japanese Ministry of Health, Labour and Welfare for asfotase alfa , an enzyme replacement
Alexion Pharmaceuticals ( ALXN -1.2% ) will report Q3 results on October 23 before the open. The conference call will begin at 10:00 am ET. Consensus view is EPS of $1.16 on revenues of $542M. Post your comment!
Alexion Pharmaceuticals (NASDAQ: ALXN ) appoints Leonard Bell, M.D., Chairman of the Board replacing the recently-deceased Max Link, Ph.D. Dr. Bell is the principal founder of the company. Post your comment!
Alexion Pharmaceuticals ( ALXN -3.3% ) Chairman Max Link, Ph.D., died unexpectedly on October 5 while on a business trip. He was 74 years old. The BOD will announce a new chairman shortly. Post your comment!
Alexion Phharmaceuticals (NASDAQ: ALXN ) presented data from two Phase 2 studies of asfotase alfa earlier today at the European Society for Pediatric Endocrinology Meeting
Alexion Pharmaceuticals (NASDAQ: ALXN ) promotes key executives. EVP and Chief Commercial Officer David Hallal promoted to COO. SVP and Chief HR Officer Clare Carmichael
By Stephen Simpson, CFA : As great as Alexion (NASDAQ: ALXN ) has shown itself to be with its orphan drug Soliris for rare kidney ailments, Intercept Pharmaceuticals (NASDAQ: ICPT ) may
The Japanese Ministry of Health, Labour and Welfare (MHLW) designates Alexion Pharmaceuticals ' (NASDAQ: ALXN ) asfotase alfa an Orphan Drug for the treatment of patients with hypophosphatasis (HPP), an ultra-rare metabolic disease
politicians. But that alone won’t stop inversions and possible future candidates with 45% or more revenues from overseas include ALXN , IPG, JCI, OI, MON . For the week , Dow +0.37% , SP500 +0.33% , Nasdaq Comp +0.42% , Russell 2000 +1.48